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ABSTRACT 
PURPOSE: To evaluate the accuracy of different parameters in predicting early (one-month) mortality of patients submitted to 
orthotopic liver transplantation (OLT). 
METHODS: This is a retrospective study of forty-four patients (38 males and 10 females, mean age of 52.2 ± 8.9 years) admitted to 
the Intensive Care Unit of a tertiary hospital. Serial lactate blood levels, APACHE II, MELD post-OLT, creatinine, bilirubin and INR 
parameters were analyzed by receiver-operator characteristic (ROC) curves as evidenced by the area under the curve (AUC). The level 
of significance was set at 0.05.
RESULTS: The mortality of OLT patients within one month was 17.3%. Differences in blood lactate levels became statistically 
significant between survivors and nonsurvivors at the end of the surgery (p<0.05). The AUC was 0.726 (95%CI = 0.593-0.835) for 
APACHE II (p = 0.02); 0.770 (95%CI = 0.596-0.849) for blood lactate levels (L7-L8) (p = 0.03); 0.814 (95%CI = 0.690-0.904) for 
MELD post-OLT (p < 0.01); 0.550 (95%CI = 0.414-0.651) for creatinine (p = 0.64);  0.705 (95%CI = 0.571-0.818) for bilirubin (p = 
0.05) and 0.774 (95%CI = 0.654-0.873) for INR (p = 0.02). 
CONCLUSION: Among the studied parameters, MELD post-OLT was more effective in predicting early mortality after OLT.
Keywords: Lactic Acid. Liver Transplantation. Severity of Illness Index. Prognosis. 
RESUMO
OBJETIVO: Avaliar qual parâmetro é o mais eficiente na predição de mortalidade precoce (um mês) de pacientes submetidos a 
transplante ortotópico de fígado (OLT). 
MÉTODOS: Estudo retrospectivo em cinqüenta e oito pacientes adultos (44 homens e 14 mulheres, com uma idade média de 51,7 ± 
10,1 anos) admitidos na Unidade de Terapia Intensiva de um hospital terciário. Os parâmetros como a dosagem seriada de lactato no 
sangue, APACHE II, MELD pós-OLT, creatinina, bilirrubina e INR foram analisados por curvas ROC (Receiver-operator characteristic), 
evidenciado pela área abaixo da curva (AUC). O nível de significância foi definido em 0,05. 
RESULTADOS: A mortalidade dos pacientes OLT em até um mês foi de 17,3%. As diferenças no nível de lactato no sangue tornaram-
se estatisticamente significantes entre sobreviventes e não sobreviventes no final da cirurgia (p < 0,05). A AUC foi de 0,726 (95%CI 
= 0,593-0,835) para APACHE II (p = 0,02); 0,770 (95%CI = 0,596-0,849) para o lactato sérico (L7-L8) (p = 0,03); 0,814 (95%CI = 
0,690-0,904) para MELD post-OLT (p < 0,01); 0,550 (95%CI = 0,414-0,651) de creatinina (p = 0,64); 0,705 (95%CI = 0,571-0,818) de 
bilirrubina (p = 0,05) e 0,774 (95%CI = 0,654-0,873) para INR (p = 0,02). 
CONCLUSÃO: Dentre os vários parâmetros estudados, o MELD pós-OLT foi o mais eficaz na predição de mortalidade precoce em 
pacientes submetidos à OLT.
Descritores: Ácido Láctico. Transplante de Fígado. Índice de Gravidade de Doença. Prognóstico.
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Introduction
The outcome of patients submitted to orthotopic liver 
transplantation (OLT) does not depend only on the quality of 
the graft, cold ischemia time and the medical condition of the 
recipient prior to the surgery. The posttransplantation outcome is 
also affected by perioperative and the immediate postoperative 
care delivered to the patient, at the Intensive Care Unit (ICU) 
arrival. Because of the set of procedures involved in OLT is highly 
complex, it is important that the factors influencing the morbidity/
mortality of OLT patients in the short-term are determined. 
Several studies have been conducted in an attempt 
to find an ideal parameter that employs clinical symptoms or 
comorbidities and that can accurately predict postoperative 
complications. Among these predictors serial perioperative blood 
lactate has been proposed to investigate the graft function and its 
hability to reduce lactate levels1,2. Furthermore, other predictors 
were also utilized such as international normalized ratio (INR)3, 
Acute Physiology and Chronic Health Evaluation II (APACHE II) 
and postoperative Model of Ende-stage Liver Disease (MELD)4.  
The aim of the present study was to investigate which 
parameter (Serial lactate blood levels, APACHE II, postoperative 
MELD, creatinine, bilirubin and INR) is the most effective in 
predicting early mortality (up to 30 post transplantation days) of 
patients submitted to OLT.
Methods
This is a retrospective study conducted in the Intensive 
Care Unit (ICU) of Clinics Hospital of Ribeirão Preto Medical 
School of the University of São Paulo, Brazil. The research 
protocol was approved by the Research Ethics Committee of 
the Clinics Hospital of Ribeirão Preto Medical School of the 
University of São Paulo.
Fifty-eight adult patients (44 males and 14 females, with 
a mean age of 51.7 ± 10.1 years) admitted to the ICU during the 
immediate OLT postoperative period were included in the study. 
The OLT procedures were performed between 2008 and 2010. 
Exclusion criteria included fulminant acute hepatitis and familial 
amyloid polyneuropathy. The type of condition (demographic, 
clinical data and scores) was observed by comparison of groups 
of patients designated survivors and nonsurvivors. Various 
indexes were employed for prediction of early mortality (up to 
30 posttransplantation days). Serial blood lactate levels was 
performed at preoperative phase or baseline (L1), every 60-90 
minutes (L2-L6) from the beginning of surgery, at the end of 
surgery (reperfusion) of the graft (L7-L8), 24 and 48 hours after 
the surgery (D1 and D2, respectively). The Data for calculation 
of the APACHE II score and the postoperative MELD (MELD 
Post-OLT) were collected during the first 24 hours after patient 
admission. The APACHE II scoring system takes account of 12 
physiological variables, as well as Glasgow coma scale, age, 
occurrence of urgent surgical procedures, and comorbidities, as 
originally described by Knaus et al.5. MELD score was determined 
after OLT (MELD post-OLT), by means of the following equation:
MELD=0.957xLoge(Creatinine*) + 0.378 x 
Loge(Bilirubin*) + 1.12xLoge(INR) + 0.643
    *Creatinine and Bilirubin are expressed in mg/dL.
Statistical analysis
An unpaired Student t test was used to compare differences 
between demographic and clinical data of patients. The values 
were reported as mean ± standard deviation (SD). The variables 
at admission such as APACHE II, MELD post-OLT, creatinine, 
bilirubin, INR, and blood lactate levels L7-L8 were analysed by 
generation of receiver operating characteristics (ROC) curves to 
determine the area of the ROC curve (AUC), as predictive factor 
for each parameter. The significance was tested using Wilcoxon 
test6. The serial blood lactate levels (from baseline to D2) were 
performed by adjusting a random effect model and, the differences 
between the groups of survivors and nonsurvivors were obtained 
by orthogonal contrasts, displayed as Log of Lactate, as described 
previously by Schall7. The significance level was set at 0.05. All 
statistical analyses were performed using SAS software version 
9.2 (SAS Institute Inc., Cary, NC, USA).
Results 
Forty-four (38 males and 10 females, with a mean age 
of 52.2 ± 8.9 years) patients survived at least 1 month after the 
surgery, whereas 10 (6 males and 4 females, with a mean age of 
49.8 ± 14.9 years) died during this period. The overall mortality 
was 17.3%. The most common indications for liver transplantation 
were alcohol-, viral-, hepatocarcinoma-induced cirrhosis and 
primay biliary cirrhosis. The APACHE II score was 14.4 ± 6.6 and 
22.2 ± 10.1 for survivors and nonsurvivors (p<0.05), respectively. 
The death risk was 17.0 ± 15.8 and 40.2 ± 32.4 for survivors 
and nonsurvivors, respectively (p<0.05). The MELD post-OLT 
was 23.4 ± 6.6 and 31.4 ± 5.7 for survivors and nonsurvivors, 
respectively (p<0.05). Demographic, clinical (including serum 
creatinine, bilirubin and INR), and etiologic data for all the OLT 
patients (survivors and nonsurvivors) are listed in Table 1.
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TABLE 1 – Demographic, clinical and etiologic data of 
patients submitted to ortothopic liver transplantation.
*Values expressed as mean ± SD (mmol/L), **p<0.05
The values for serial blood lactate levels (lactate and Log 
of Lactate) between survivors and nonsurvivors, as summarized 
in Table 2 and depicted in Figure 1. This parameter became 
significantly different between survivors and nonsurvivors just 
before the end of the surgery (L7), thereby remaining the rest of 
the study (L8 to D2) (p<0.05).
TABLE 2 – Serial lactate blood levels (L) of patients 
survivors and nonsurvivors of liver Transplantation (Preoperative 
and Perioperative phases, 24 and 48 hours after the surgery).
*Values expressed as mean ± SD (mmol/L), **p<0.05
FIGURE 1 – Boxplot of serial lactate blood levels (represented as Log 
of Lactate), distributed by group (survivors and nonsurvivors) and time 
interval.
TIME VARIABLE SURVIVORS NONSURVIVORS
L1 – Baseline 
(Preoperative)
 Lactate*
Log of Lactate 
1.67±0.52
0.47±0.31
1.73±0.71
0.47±0.43
L2 (Beginnig of 
the Surgery)
Lactate
Log of Lactate
2.59±0.89
0.89±0.38
2.16±0.89
0.69±0.42
L3 LactateLog of Lactate
3.85±1.08
1.31±0.28
3.31±1.54
1.08±0.56
L4
Lactate
Log of Lactate
4.49±1.41
1.45±0.32
4.93±2.38
1.50±0.45
L5 LactateLog of Lactate
5.18±1.65
1.59±0.34
6.34±3.07
1.75±0.45
L6
Lactate
Log of Lactate
5.10±1.97
1.55±0.40
6.98±4.30
1.81±0.51
L7 LactateLog of Lactate
4.87±2.40
1.48±0.47
    7.37±4.45**
1.84±0.61
L8 (End of 
the surgery)
Lactate
Log of Lactate
4.38±2.31
1.38±0.43
    8.56±5.55**
1.99±0.58
LD1 (24 hours 
after surgery)
Lactate
Log of Lactate
2.61±1.96
0.80±0.54
   9.13±9.81**
1.71±1.07
LD2 (48 hous 
after surgery)
Lactate
Log of Lactate
2.26±2.00
0.64±0.53
  10.65±12.52**
1.74±1.19
Patients 
(n=58)
    Survivors 
(n=48)         
    Nonsurvivors 
(n=10)
Sex (M/F) 38/10 6/4 
Age (years) 52.2 ± 8.9 49.8 ± 14.9
APACHE II 14.4 ± 6.6 22.2 ± 10.1*
Death Risk (%) 17.0 ± 15.8 40.2 ±32.4*
Creatinine (mg/L) 1.6 ± 1.3 1.8 ± 1.1
Bilirubin (mg/L) 4.7 ± 3.2 10.7 ± 11.6*
INR 2.3 ± 0.9 6.4 ± 5.2*
MELD post-OLT 23.4 ± 6.6 31.4 ± 5.7*
Hepatocellular Carcinoma 9 4
Alcoholic Cirrhosis 19 2
Hepatitis Virus B 1 0
Hepatitis Virus C 11 1
Primary Biliary Cirrhosis 4 2
Others 4 1
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The AUC was 0.726 (95%CI = 0.593-0.835) for APACHE 
II (p = 0.02); 0.770 (95%CI = 0.596-0.849) for blood lactate levels 
(L7-L8) (p = 0.03); 0.814 (95%CI = 0.690-0.904) for MELD post-
OLT (p < 0.01); 0.550 (95%CI = 0.414-0.651) for creatinine (p = 
0.64);  0.705 (95%CI = 0.571-0.818) for bilirubin (p = 0.05) and 
0.774 (95%CI = 0.654-0.873) for INR (p = 0.02), as demonstrated 
in Table 3. It was observed that the AUC for MELD post-OLT was 
higher than the AUC for other parameters.
TABLE 3 – Area under the curve (AUC) of receiving 
operator characteristics (ROC) for different predictors at ICU 
admission. 
Discussion
The main goal of the present investigation was to carry 
out a follow-up on a series of recently published investigations on 
the exhaustive search for a parameter capable of predicting the 
early mortality (up to one month) of patients submitted to OLT. 
The examination of these references of the current literature trends 
concerning this topic, point out to the fact that the physiologic 
and/or clinical factors concerning severity at ICU arrival and 
comorbidities present before the surgery are a relevant issue. In 
this sense, the methodology and results of the present investigation 
are similar to those that employed different parameters, acting as 
predictors, published elsewhere4,8,9. However, current indexes 
are unable to accurately predict which patients will have a high 
probability of posttransplant survival. For this reason, the search 
for a prognostic factor to predict early mortality of patients 
submitted to OLT still remains. Among the parameters most 
frequently utilized for prediction of early mortality in OLT 
patients, the perioperative blood lactate levels, the APACHE II, 
the INR and the MELD post-OLT seem to be more precise.
The metabolic fate of lactate metabolism has been 
challenging scientists around the world throughout the past 
decades. Indeed, more than being considered as an end-product 
of anaerobic glycolysis, indicator of tissue hypoperfusion and 
hypoxia, because of an imbalance between oxygen supply and 
oxygen demand, this metabolite has a particular role in different 
metabolic pathways. This includes insulin release, regulation of 
plasma glucose and modulation of energy homeostasis10. The 
serial blood lactate monitoring has been assessed in the critically ill 
patient in many situations11 demonstrated that persistent elevation 
of blood lactate level in septic patients can be a reliable predictor 
of multiple organ failure syndrome and poor prognosis. Thus, in 
the ICU setting the study of the behavior of this metabolite in 
severe sepsis or septic shock is gaining terrain even more, since 
the reduction of elevated blood lactate level is considered to be 
the primary target of the treatment of the critically ill patient12-14.  
The hepatic tissue has a great capability to convert 
lactate to pyruvate through lactate deshydrogenase and then into 
glycogen. Consequently, the impairment of liver function after 
the graft transplantation provoked by systemic hypoperfusion, 
hypoxia and acidosis are responsible for a low clearance of 
lactate, especially after the reperfusion. Therefore, in the case of 
liver transplantation, the perioperative blood lactate levels had 
shown a close relationship with survival rates shortly after ICU 
admission. In this context, De Gasperi et al.1 recorded the blood 
lactate levels and prothrombin times in all perioperative phases of 
53 postnecrotic cirrhotic patients submitted to OLT. These authors 
observed an increase of lactate levels during the preanhepatic 
and anhepatic stages, followed by a peak of lactate level after 
the graft revascularization (>4 mmol/L), associated to a higher 
prothrombin time in some patients, becoming significant after 
the end of the surgery. It was stated that more than an absolute 
value, the blood lactate appears to be a useful indicator of hepatic 
metabolic recovery of its functional capabilities in the immediate 
postoperative period of OLT. Additionally, Nishimura et al.2 
conducted a study in 15 living donors liver transplantation and 
it was observed that the lactate clearance is associated to the size 
of the graft.  The proposal of this investigation is that the lactate 
elimination is a reliable independent predictor of hepatic function 
and early mortality after liver transplantation. 
Despite the importance of lactate metabolism playing 
a pivotal role as a probe of hepatic functioning, some others 
parameters may reflect the clinical condition of the patient at ICU 
admission and predict early mortality of OLT patients. However, 
it should be emphasized that a definitive index for the accurate 
prediction of survival rate and/or early mortality after OLT has not 
yet been developed.
In this particular task, a number of attempts using 
different approaches to explore this matter were undertaken. Volk 
et al.8 verified that the Charlson comorbidity index can be applied 
for prediction of mortality after liver transplantation, because the 
Variable AUC 95%CI P value
APACHE II 0.726 0.593-0.835 0.02
Blood Lactate 
L7-L8 (mmol/L)
0.770 0.596-0.849 0.03
MELD post-OLT 0.814 0.690-0.904 < 0.01
Creatinine (mg/dL) 0.550 0.414-0.651 0.64
Bilirubin (mg/dL) 0.705 0.571-0.818 0.05
INR 0.774 0.645-0.873 0.02
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most frequently detected comorbidities in the patients with poor 
outcome were coronariopathy, diabetes, chronic obstructive lung 
diseases, autoimmune diseases, and need for renal replacement 
therapy. On the other hand, the MELD score could also be used to 
predict early mortality after OLT, since this score is based on three 
physiological serum variables (creatinine, bilirubin and INR). 
Siniscalch et al.9 demonstrated that patients with and without 
posttransplantation complications had slightly different mean 
MELD scores, equal to 22.8 and 17.8, respectively. In a previous 
study carried out in our ICU, we observed that the mean MELD 
pre-OLT score was 20.1 and 19.2 for survivors and nonsurvivors, 
respectively. The prediction of early mortality was not satisfactory, 
since the area under the ROC curve was only 0.50. Interestingly, 
when this index was calculated within the first 24 postoperative 
hours (MELD post-OLT), the mean values found for survivors 
and nonsurvivors presented significant differences (23.3±6.8 and 
31.0±5.9, respectively) and the area under the ROC curve was 
0.744.
The APACHE II system is one of the prognostic indexes 
most employed for correlation between expected/observed 
mortality and risk of death in critically ill patients in ICUs 
worldwide. This score is based in physiologic measurements, age 
and comorbidities. Karvellas et al.15 observed that a combination 
of the MELD and APACHE II scores was useful for prediction of 
bacteremia in patients with acute liver failure. In a representative 
number of patients, it was showed that 36% of them presented 
bacteremia (mainly gram negative bacteria). The authors also 
demonstrated that high MELD and APACHE II scores were 
correlated with length of mechanical ventilation, need for dialysis, 
and lower survival. 
Nevertheless, our data provide a different perspective, 
since we observed a close profile among the various parameters 
studied when MELD post-OLT, INR, serial blood lactate levels 
and APACHE II were utilized as predictors, demonstrating 
the contribution of these parameters to the prediction of early 
mortality of OLT patients. Data from the present study point to 
the fact that these parameters can be employed in this situation, 
particularly when these data were confirmed by the ROC curve, 
which furnished area under the curve equal to 0.814, 0.774, 0.770 
and 0.726, respectively. 
Conclusions
Among the studied parameters, it seems that the MELD 
post-OLT performed better in predicting early mortality of patients 
after orthotopic liver transplantation. Moreover, data from our 
present study should make transplant team members aware of the 
fact that the use of parameters, such as perioperative blood lactate 
levels, APACHE II, INR together with MELD post-OLT, might 
indicate which patients are at higher risk of early mortality (up 
to 30 posttransplantation days). Further investigations should be 
encouraged to reproduce these findings.
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